Novartis bids to buy U.S. vaccine maker Chiron
Novartis today offered $4.5 billion to purchase the remaining shares of U.S. drugmaker Chiron in a bid to gain a ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.